Junmin Chen
Impact in
-
- Intensive Care Unit Cognitive Disorders
- Biochemistry top 5%
- Blood transfusion and management
Papers in
-
- Protein Degradation and Inhibitors 4
- Bone Metabolism and Diseases 3
- PI3K/AKT/mTOR signaling in cancer 3
- Hematology 16
- Multiple Myeloma Research and Treatments 11
- Co-authors
- Wenzhong Que (7 shared papers)Zhiyong Zeng (23 shared papers)Haoran Zhang (2 shared papers)Chao Liu (4 shared papers)Kunshen Liu (3 shared papers)Yanqiu Gao (2 shared papers)Yueping Li (1 shared paper)Shuo Wang (1 shared paper)
- Journals
- Cochrane Database of Systematic Reviews (4 papers)Molecular Carcinogenesis (2 papers)International Journal of Molecular Medicine (2 papers)Cell Communication and Signaling (2 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Junmin Chen
49 papers receiving 1.1k citations
Junmin Chen's Hit Papers
Peers
Comparison fields: 5 of 105
- Critical Care and Intensive Care Medicine 119
- Biochemistry 126
- Hematology 146
- Internal Medicine 23
- Rheumatology 86
Countries citing papers authored by Junmin Chen
This map shows the geographic impact of Junmin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Chen more than expected).
Fields of papers citing papers by Junmin Chen
This network shows the impact of papers produced by Junmin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Chen. The network helps show where Junmin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Junmin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 188 | |
| 2 | Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases Hit paper breakdown → | 2024 | 175 |
| 3 | 2011 | 162 | |
| 4 | 2013 | 101 | |
| 5 | 2013 | 60 | |
| 6 | 2016 | 51 | |
| 7 | 2011 | 46 | |
| 8 | 2012 | 32 | |
| 9 | 2011 | 26 | |
| 10 | 2021 | 24 | |
| 11 | 2013 | 22 | |
| 12 | 2013 | 21 | |
| 13 | 2005 | 20 | |
| 14 | 2013 | 18 | |
| 15 | 2016 | 16 | |
| 16 | 2019 | 15 | |
| 17 | 2021 | 14 | |
| 18 | 2020 | 12 | |
| 19 | 2018 | 12 | |
| 20 | 2021 | 8 |
About Junmin Chen
Junmin Chen is a scholar working on Molecular Biology, Hematology, Oncology, Rheumatology and Genetics, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Protein Degradation and Inhibitors (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Bone Metabolism and Diseases (3 papers), Peptidase Inhibition and Analysis (3 papers), Mesenchymal stem cell research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (119 citations), Biochemistry (126 citations), Hematology (146 citations), Internal Medicine (23 citations) and Rheumatology (86 citations). Junmin Chen has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Wenzhong Que, Zhiyong Zeng, Haoran Zhang, Chao Liu, Kunshen Liu, Yanqiu Gao, Yueping Li, Shuo Wang, Rongfang Hu and David Evans. Their work appears in journals such as Cochrane Database of Systematic Reviews, Molecular Carcinogenesis, International Journal of Molecular Medicine, Cell Communication and Signaling and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.